Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China

Shiyi Gong,1 Hao Hu,2 Kun Zhao,2 Ting Yang1 1Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Disease; Institute of Respiratory Medicine, Chinese Academy of Medical Science; Peking University Health Science Center,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Gong S, Hu H, Zhao K, Yang T
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2021-02-01
coleção:	International Journal of COPD
Assuntos:	copd dual bronchodilator cost-effectiveness analysis china
Acesso em linha:	https://www.dovepress.com/cost-effectiveness-of-dual-bronchodilator-indacaterolglycopyrronium-fo-peer-reviewed-article-COPD
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!